Similar articles

• [Genetic risk factor for the onset and progression of diabetic complication].

  Nakajima K, Tanaka Y. Nakajima K, et al. Nihon Rinsho. 2002 Oct;60 Suppl 10:95-101. Nihon Rinsho. 2002. PMID: 12430213 Review. Japanese. No abstract available.
• Vascular and haemostatic gene polymorphisms associated with non-fatal myocardial infarction: a critical review.

  Manzoli A, Andreotti F, Leone AM, Sperti G, Zecchi P, Di Sciascio G. Manzoli A, et al. Ital Heart J. 2000 Mar;1(3):184-93. Ital Heart J. 2000. PMID: 10806985 Review.
• [Polymorphisms in genes for cholesterol ester transfer protein, apolipoprotein C-III and lipoprotein lipase in children with high and low cholesterol levels] ].

  Hubácek JA, Pistulková H, Skodová Z, Lánská V, Poledne R. Hubácek JA, et al. Cas Lek Cesk. 2001 Feb 15;140(3):79-81. Cas Lek Cesk. 2001. PMID: 11284423 Czech.
• Genotypic interactions of renin-angiotensin system genes in myocardial infarction.

  Araújo MA, Goulart LR, Cordeiro ER, Gatti RR, Menezes BS, Lourenço C, Silva HD. Araújo MA, et al. Int J Cardiol. 2005 Aug 3;103(1):27-32. doi: 10.1016/j.ijcard.2004.07.009. Epub 2004 Dec 15. Int J Cardiol. 2005. PMID: 16061119
• The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.

  Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR. Doggen CJ, et al. Thromb Haemost. 1999 Jul;82(1):115-20. Thromb Haemost. 1999. PMID: 10456464